Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis

Orthopedics. 2010 Dec;33(12):902. doi: 10.3928/01477447-20101021-21.

Authors

Joel A Horning¹, John Czajka, Richard L Uhl

Affiliation

¹ The Division of Orthopedic Surgery, Albany Medical Center, Albany, New York, USA.

PMID: 21117565
DOI: 10.3928/01477447-20101021-21

No abstract available

MeSH terms

Bone Density Conservation Agents / adverse effects
Bone Density Conservation Agents / therapeutic use
Diphosphonates / adverse effects*
Diphosphonates / therapeutic use*
Femoral Fractures / chemically induced*
Femoral Fractures / prevention & control*
Humans
Osteoporosis / complications
Osteoporosis / drug therapy*
Osteoporotic Fractures / chemically induced*
Osteoporotic Fractures / prevention & control*

Substances

Bone Density Conservation Agents
Diphosphonates